OnKure Therapeutics, Inc.

OKUR
$4.58 (+ $0.12 + 2.69%)
Last updated: 2026-07-04 10:26 UTC
OKUR Metrics
Exchange
🇺🇸 NASDAQ XNMS
Nasdaq/NMS (Global Market)United StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS68277Q1058
CUSIP68277Q105
Market Price4.58
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-4.72
Market Cap$38.6M
Book Value4.9
Price to Book0.581
BetaN/A
52w High9.4
52w Low1.7
Next Earnings DateN/A

OnKure Therapeutics, Inc. trades under ticker OKUR on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US68277Q1058, CUSIP 68277Q105.

About the Company
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3 kinase alpha harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company is headquartered in Boulder, Colorado.
Price History